LONG-TERM EFFECTIVENESS AND ACCEPTABILITY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: THE REMSWITCH-LT STUDY
Anthony Buisson 1
Maria Nachury 2
Maƫva Bazoges 2
Clara Yzet 3
Pauline Wils 4
Marie Dodel 4
Dilek Coban 4
Bruno Pereira 4
Mathurin Fumery 4
1 CHU Estaing Clermont-Ferrand, Clermont-Ferrand, France
2 CHRU Lille, Courbevoie Cedex, France
3 Amiens University Hospital, Amiens, France
4 CHRU Lille, Lille Cedex, France
Topic
IBD
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]